http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201103996-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bfd9c2c1decf731d6409d54652793e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 |
| filingDate | 2011-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe9de16c42d5e04b91a7c0955ac6e3e |
| publicationDate | 2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TR-201103996-A1 |
| titleOfInvention | Combined dosage forms with synergistic effect. |
| abstract | The present invention relates to a pharmaceutical combination comprising dexlansoprazole and domperidone as the active ingredient, a dosage form comprising said combination and the use of this combination in the treatment of acid-related gastrointestinal disorders, in particular in the treatment of diseases associated with gastroesophageal reflux. |
| priorityDate | 2011-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.